Marina Gonçalves
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marina Gonçalves has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Carlos Silva
Urology Department, São João Local Health Unit, Porto, Portugal; Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal
1 shared publication - Carolina Dias
Institute for Research and Innovation in Health (i3S), University of Porto, Rua Alfredo Allen 208, 4200-135 Porto, Portugal
1 shared publication - Diana Martins
Faculty of Medicine, University of Porto, Alameda Professor Hernâni Monteiro, 4200-319 Porto, Portugal
1 shared publication - José Manuel Lopes
Institute for Research and Innovation in Health (i3S), University of Porto, Rua Alfredo Allen 208, 4200-135 Porto, Portugal
1 shared publication - João Silva
Faculty of Medicine, University of Porto, Alameda Professor Hernâni Monteiro, 4200-319 Porto, Portugal
1 shared publication Miguel Barbosa
Medical Oncology, Centro Hospitalar Universitário de São João, Porto, PRT
1 shared publication
Latest Publications
- Open Access
- 19 January 2025
- Published by Springer Nature in Cureus
- Vol. 17 (1) , e77670
Bridging Communication Gaps in Oncology: Insights From a Questionnaire Among Internal Medicine and Intensive Care Physicians
Introduction Oncology has rapidly evolved over the past decades in terms of treatments and outcomes. However, it has also introduced challenges, particularly for non-oncologist physicians who, at some stage of the disease, encounter oncology patients. The increasing complexity of terminology, lack of updated knowledge, or insufficient training, along with other interdisciplinary communication barriers, can lead to less-informed clinical decisions, resulting in suboptimal treatment management. Objective This study aims to investigate knowledge and communication limitations with oncology among internal medicine and intensive care physicians to identify educational and operational gaps. Methods This was a quantitative study using a questionnaire administered to internal medicine and intensive care specialists and residents (third to fifth year) from three centers. Data was analyzed using SPSS software. Results A total of 91 responses were obtained (69 (75.8%) from internal medicine and 22 (24.2%) from intensive care), of which 76.9% (n=70) were specialists. Approximately 92.3% (n=84) reported daily or weekly contact with oncology patients. Fifty-eight percent (n=53) rated their knowledge of oncology terminology as “adequate,” and 93.4% (n=85) disagreed that "first-line palliative treatment" and "first-line metastatic treatment" have the same meaning. The majority (72.5%, n=66) considered the terminology used to be “unclear,” particularly in relation to prognosis. In 72.5% (n=66) of cases, respondents reported that clinical decisions could have been altered if more objective terminology had been used. More than 90% (more than n=82) supported the need for standardized oncology terminology and clinical summaries with prognostic information. Around 93.4% (n=85) stated that continuous education in oncology should be more accessible. Conclusions The study revealed significant gaps in communication and knowledge of oncology among non-oncologist physicians, highlighting the need for standardized terminology and greater accessibility to continuous education. These measures could improve oncology care and potentially influence health policies.
- 19 January 2025
- Published by Springer Nature in Cureus
- Vol. 17 (1) , e77670
Open AccessBridging Communication Gaps in Oncology: Insights From a Questionnaire Among Internal Medicine and Intensive Care Physicians
Introduction Oncology has rapidly evolved over the past decades in terms of treatments and outcomes. However, it has also introduced challenges, particularly for non-oncologist physicians who, at some stage of the disease, encounter oncology patients. The increasing complexity of terminology, lack of updated knowledge, or insufficient training, along with other interdisciplinary communication barriers, can lead to less-informed clinical decisions, resulting in suboptimal treatment management. Objective This study aims to investigate knowledge and communication limitations with oncology among internal medicine and intensive care physicians to identify educational and operational gaps. Methods This was a quantitative study using a questionnaire administered to internal medicine and intensive care specialists and residents (third to fifth year) from three centers. Data was analyzed using SPSS software. Results A total of 91 responses were obtained (69 (75.8%) from internal medicine and 22 (24.2%) from intensive care), of which 76.9% (n=70) were specialists. Approximately 92.3% (n=84) reported daily or weekly contact with oncology patients. Fifty-eight percent (n=53) rated their knowledge of oncology terminology as “adequate,” and 93.4% (n=85) disagreed that "first-line palliative treatment" and "first-line metastatic treatment" have the same meaning. The majority (72.5%, n=66) considered the terminology used to be “unclear,” particularly in relation to prognosis. In 72.5% (n=66) of cases, respondents reported that clinical decisions could have been altered if more objective terminology had been used. More than 90% (more than n=82) supported the need for standardized oncology terminology and clinical summaries with prognostic information. Around 93.4% (n=85) stated that continuous education in oncology should be more accessible. Conclusions The study revealed significant gaps in communication and knowledge of oncology among non-oncologist physicians, highlighting the need for standardized terminology and greater accessibility to continuous education. These measures could improve oncology care and potentially influence health policies.
- Open Access
- 2 January 2023
- Published by MDPI AG in Diagnostics
- Vol. 13 (1) , 153
Prognostic Value of Bladder Involvement in the Outcome of Upper Tract Urothelial Carcinoma
Accurately predicting the clinical prognosis of upper tract urothelial carcinoma (UTUC) seems crucial. We evaluated the effect of the involvement of urothelial bladder carcinoma (UBC) as a potential prognostic factor for overall survival (OS) and progression-free survival (PFS). The cohort included 115 patients with UTUC, subgrouped between January 2009 and December 2019 as follows: (1) only UTUC and (2) UTUC with synchronous or metachronous UBC (UTUC + UBC). Univariate and multivariate analyses were performed to identify independent prognostic factors for OS and PFS. Synchronous or metachronous UBC diagnosis in UTUC patients was an independent predictor of worse PFS (HR 3.326 CI 95% 1.474–7.503, p = 0.004), but it was not identified as a prognostic factor for OS (p > 0.05). Lymphovascular invasion (LVI) was associated with decreased PFS (HR 2.687 CI 95%1.172–6.163, p = 0.020) and OS (HR 4.980 CI 95%1.763–14.064, p = 0.002). This study indicates that concomitant or later UBC could predict a poor PFS, but it is not associated with a significantly worse OS in UTUC patients. The prognostic impact of LVI underlines its inclusion in the tumor staging system of UTUC.
- 2 January 2023
- Published by MDPI AG in Diagnostics
- Vol. 13 (1) , 153
Open AccessPrognostic Value of Bladder Involvement in the Outcome of Upper Tract Urothelial Carcinoma
Accurately predicting the clinical prognosis of upper tract urothelial carcinoma (UTUC) seems crucial. We evaluated the effect of the involvement of urothelial bladder carcinoma (UBC) as a potential prognostic factor for overall survival (OS) and progression-free survival (PFS). The cohort included 115 patients with UTUC, subgrouped between January 2009 and December 2019 as follows: (1) only UTUC and (2) UTUC with synchronous or metachronous UBC (UTUC + UBC). Univariate and multivariate analyses were performed to identify independent prognostic factors for OS and PFS. Synchronous or metachronous UBC diagnosis in UTUC patients was an independent predictor of worse PFS (HR 3.326 CI 95% 1.474–7.503, p = 0.004), but it was not identified as a prognostic factor for OS (p > 0.05). Lymphovascular invasion (LVI) was associated with decreased PFS (HR 2.687 CI 95%1.172–6.163, p = 0.020) and OS (HR 4.980 CI 95%1.763–14.064, p = 0.002). This study indicates that concomitant or later UBC could predict a poor PFS, but it is not associated with a significantly worse OS in UTUC patients. The prognostic impact of LVI underlines its inclusion in the tumor staging system of UTUC.